Safety Shot, Inc. (NASDAQ:SHOT) Short Interest Update

Safety Shot, Inc. (NASDAQ:SHOTGet Free Report) was the recipient of a large decline in short interest during the month of September. As of September 15th, there was short interest totalling 4,040,000 shares, a decline of 18.2% from the August 31st total of 4,940,000 shares. Currently, 12.4% of the company’s stock are sold short. Based on an average trading volume of 1,030,000 shares, the days-to-cover ratio is presently 3.9 days.

Institutional Investors Weigh In On Safety Shot

Hedge funds have recently made changes to their positions in the business. Diversify Advisory Services LLC bought a new stake in shares of Safety Shot during the 1st quarter worth $36,000. Traynor Capital Management Inc. bought a new stake in shares of Safety Shot during the 1st quarter worth $51,000. Finally, XTX Topco Ltd bought a new stake in shares of Safety Shot during the 2nd quarter worth $84,000. 12.55% of the stock is currently owned by institutional investors.

Safety Shot Price Performance

SHOT traded down $0.02 during mid-day trading on Friday, reaching $1.17. 262,199 shares of the stock were exchanged, compared to its average volume of 1,215,696. The company has a 50 day moving average price of $0.97 and a two-hundred day moving average price of $1.36. Safety Shot has a 1 year low of $0.55 and a 1 year high of $7.50.

Safety Shot (NASDAQ:SHOTGet Free Report) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.16) earnings per share (EPS) for the quarter. The firm had revenue of $0.71 million for the quarter. Safety Shot had a negative return on equity of 542.31% and a negative net margin of 2,494.21%.

Safety Shot Company Profile

(Get Free Report)

Safety Shot, Inc, a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen.

Featured Articles

Receive News & Ratings for Safety Shot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safety Shot and related companies with MarketBeat.com's FREE daily email newsletter.